Positron emission tomography-based molecular imaging biomarkers may predict therapeutic response and survival in patients with metastatic castration-resistant prostate cancer, researchers say. READ MORE
A new prostate cancer grading system (PCGS) predicts survival rates after radical prostatectomy for men with high-Gleason score (GS) disease.
Research in Review
Patients choosing surveillance over aggressive treatment for prostate cancer are not being monitored as closely as they should be, according to a new study published by a team of University of California, Los Angeles (UCLA) researchers in the journal Cancer.